Xiaoling Xu

Zhuhai, 519031, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

GSDME mediated pyroptosis drives CCL5 secretion and dictates proteasome inhibitor efficacy in solid tumors.

GSDME mediated pyroptosis drives CCL5 secretion and dictates proteasome inhibitor efficacy in solid tumors.

Journal: Pharmacological research

Published: April 24, 2026

A miniaturized-tumor culture platform for developing anti-tumor immunotherapies.

A miniaturized-tumor culture platform for developing anti-tumor immunotherapies.

Journal: Theranostics

Published: January 26, 2026

Recent progresses in cancer multidrug resistance and therapeutic options associated with protein damage response.

Recent progresses in cancer multidrug resistance and therapeutic options associated with protein damage response.

Journal: Protein & cell

Published: January 22, 2026

B─O-Bond-Mediated π-Extension Enables Concurrent High Efficiency and Spectral Purity Toward BT.2020-Standard Deep-Blue MR-TADF OLEDs.

B─O-Bond-Mediated π-Extension Enables Concurrent High Efficiency and Spectral Purity Toward BT.2020-Standard Deep-Blue MR-TADF OLEDs.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: October 22, 2025

Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance.

Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: September 25, 2025

Dasatinib Inhibits Basal B Breast Cancer Through ETS1-Mediated Extracellular Matrix Remodeling.

Dasatinib Inhibits Basal B Breast Cancer Through ETS1-Mediated Extracellular Matrix Remodeling.

Journal: Biomedicines

Published: September 18, 2025

Pericyte NNMT drives an immune-hostile vascular niche and restricts cancer immunotherapy.

Pericyte NNMT drives an immune-hostile vascular niche and restricts cancer immunotherapy.

Journal: Science bulletin

Published: August 28, 2025

Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity.

Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: August 11, 2025

Tumor cell intrinsic dsRNA innate immune response triggered by PARP inhibitor is compromised in BRCA1-deficient breast cancer by repressing IRF3.

Tumor cell intrinsic dsRNA innate immune response triggered by PARP inhibitor is compromised in BRCA1-deficient breast cancer by repressing IRF3.

Journal: Protein & cell

Published: July 03, 2025

Identification of exosome-related genes signature based on bioinformatics and machine learning for prognostic prediction in colorectal cancer.

Identification of exosome-related genes signature based on bioinformatics and machine learning for prognostic prediction in colorectal cancer.

Journal: Discover oncology

Published: June 26, 2025

Transmembrane protein TMEM98 as a multifunctional regulator in cancer: from signaling pathways to translational implications.

Transmembrane protein TMEM98 as a multifunctional regulator in cancer: from signaling pathways to translational implications.

Journal: Journal of translational medicine

Published: June 21, 2025

Integrative multi-omics identification and functional validation of potential targets linking metabolism-immune-colorectal cancer causal pathway.

Integrative multi-omics identification and functional validation of potential targets linking metabolism-immune-colorectal cancer causal pathway.

Journal: Frontiers in immunology

Published: June 19, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026